Warren Buffett’s Berkshire Hathaway has 32% of its $291 billion portfolio invested in four major companies quietly embracing ...

William Blair analysts project AbbVie to earn $16.15 per share by FY2028, a notable jump from its current $12.31 estimate.

Truist Financial has reiterated its “buy” rating for Alphabet with a bold $200 price target, signaling confidence in the tech ...

Precedent Wealth Partners LLC reduced its Amazon holdings by 3.9% in Q1, selling 227 shares worth about $1,075,000. Other ...

Qualcomm stock gained 28.2% in three months, outperforming some rivals but trailing others. Qualcomm’s Snapdragon 8 Elite ...

K.J. Harrison & Partners reduced its JPMorgan Chase stake by 42.7% in the first quarter, selling over 26,000 shares. This ...

Retirement Planning Group LLC shaved a minuscule 0.1% off its Apple holdings in Q1, selling just 72 shares—hardly ...

UBS recently adjusted its price target for UnitedHealth Group from $400 to $385, citing a conservative 2025 earnings outlook ...

Mastercard remains a titan in the booming $3 trillion digital payments market, with innovations and global expansion fueling ...

Novem Group ramped up its Southern Copper stake by 34.4% in the first quarter, showing clear bullish confidence in the mining ...

Riverview Trust slightly reduced its Microsoft stake but still considers it a top holding worth over $3.8 million. Insider ...

Nvidia surged toward becoming the most valuable company in history, briefly topping a $3.92 trillion valuation on Thursday.